Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

EGFR helps protect hair follicles from damage and scarring.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.